SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950134-01-003081
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
4
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 2000 d85742e10-k405.txt 10-K405 202096
2 2000 STOCK OPTION PLAN d85742ex10-40.txt EX-10.40 30893
3 EMPLOYMENT AGREEMENT - RONALD LANE GOODE PHD d85742ex10-41.txt EX-10.41 38195
4 CONSENT OF INDEPENDENT AUDITORS d85742ex23.txt EX-23 877
  Complete submission text file 0000950134-01-003081.txt   273971
Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD STE 330 DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-26078 | Film No.: 1591154
SIC: 2834 Pharmaceutical Preparations